查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922385

日本血液分离术市场报告：按组件、产品、技术、流程、应用、最终用户和地区划分（2026-2034 年）

Japan Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本血液分离术市场规模达1.513亿美元。 IMARC集团预测，到2034年，该市场规模将达到2.56亿美元，2026年至2034年的复合年增长率（CAGR）为6.02%。推动市场成长的关键因素包括：癌症、自体免疫疾病和血液相关疾病等慢性病发病率的上升趋势；血液分离术设备的快速技术进步；医护人员和患者对血液分离术益处的认识不断提高；以及对医疗基础设施的大量投资。

血液分离术是一种用于治疗目的的医疗程序，旨在从捐血者或患者体内分离并去除特定的血液成分。该过程使用称为血液分离机的精密仪器，选择性地提取和保存血液成分，例如血浆、血小板、红血球和白血球。根据目标成分的不同，分离方法可以是离心或过滤。血液分离术的主要治疗应用之一是治疗各种疾病，包括自体免疫、血液系统疾病和神经系统疾病。例如，在多发性硬化症和重症肌无力等自体免疫疾病中，血液分离术可以去除患者血液中的有害抗体，从而减轻疾病的影响。同样，在白血病等血液系统疾病中，血液分离术可以帮助收集用于治疗或移植的特定血液成分。此外，血液分离术在捐血过程中也发挥着重要作用，它允许收集各种医疗程序所需的特定成分，同时将剩余成分输回捐血。这种有针对性地采集血液成分的方法提高了捐血效率，并确保了医疗干预所需的血液製品的稳定和多样化供应。不断发展的血液成分分离术持续推动与治疗和捐血相关的医疗实践，为临床医生提供了强大的工具，使其能够选择性地管理血液成分，从而造福面临各种健康挑战的患者。

日本血液分离术市场的发展趋势：

日本市场的主要驱动力是不断扩展的治疗应用。血液分离设备技术的快速发展显着促进了市场成长。设备设计、自动化和血液成分分离精度的持续创新，提高了血液分离术的效率和安全性，使其更易于获取，也更受医疗机构的青睐。这些技术进步也缩短了手术时间，提高了患者的舒适度，进一步促进了血液分离术在临床环境中的应用。此外，慢性病和自体免疫疾病的日益普遍也推动了对血液分离术的需求。癌症、自体免疫疾病和血液系统疾病等需要有针对性地移除或收集特定血液成分，以控制症状或增强治疗效果。血液分离术作为一种重要的治疗性介入手段，能够选择性地提取与疾病相关的成分，从而有助于疾病管理和改善患者预后。随着慢性病负担的不断加重，预计血液分离术作为治疗选择的需求将会成长。此外，血液分离术治疗应用范围的不断扩大也提升了其市场潜力。血液分离术的应用范围正从传统领域扩展到包括神经病学、肾臟病学和血液病学在内的多个医学领域。这种应用的多元化使血液分离术成为各种医疗环境中用途广泛且实用的工具，从而促进了市场的持续成长。此外，医疗专业人员对血液分离术在治疗多种疾病方面的益处认识的不断提高，也进一步推动了其应用。

本报告解答的关键问题

  • 日本血液分离术市场目前发展如何？您预计未来几年它将如何发展？
  • 新冠疫情对日本血液分离术市场产生了哪些影响？
  • 日本血液分离术市场按市场组成部分是如何分類的？
  • 日本血液分离术市场的产品区隔如何？
  • 日本血液分离术市场依技术划分是怎样的？
  • 日本血液分离术市场依手术项目分類的组成是怎样的？
  • 日本血液分离术市场按应用领域是如何分類的？
  • 日本血液分离术市场依最终用户分類的组成是怎样的？
  • 日本血液分离术市场价值链的各个阶段有哪些？
  • 日本血液分离市场的主要驱动因素和挑战是什么？
  • 日本血液分离术市场的结构是怎么样的？主要参与者有哪些？
  • 日本血液分离术市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本血液分离市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本血液分离术市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本血液分离市场－依成分细分

  • 血浆（血浆置换术）
  • 血小板（血小板分离法）
  • 白血球（白血球分离术或白血球分离术）
  • 淋巴球（淋巴球分离或淋巴球分离疗法）
  • 红血球（红血球分离术）

第七章 日本血液分离市场－依产品细分

  • 装置
  • 耗材和试剂
  • 软体

第八章：日本血液分离市场－依技术细分

  • 离心
  • 膜分离
  • 选择性吸附

第九章：日本血液分离市场－依方法细分

  • 供体/自动化血浆分离术
  • 治疗性血液分离术

第十章 日本血液分离市场－依应用领域细分

  • 肾臟疾病
  • 血液疾病
  • 神经系统疾病
  • 自体免疫疾病
  • 其他的

第十一章 日本血液分离市场－依最终用户细分

  • 血液中心
  • 医院
  • 其他的

第十二章 日本血液分离市场－依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十三章：日本血液分离市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十四章主要企业简介

第十五章 日本血液分离市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十六章附录

简介目录
Product Code: SR112026A19379

Japan apheresis market size reached USD 151.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 256.0 Million by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034 . The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and blood-related conditions, the rapid technological advancements in apheresis equipment, the rising awareness among healthcare professionals and patients about the benefits of apheresis procedures, and the heavy investments in healthcare infrastructure are some of the factors propelling the market.

Access the full market insights report Request Sample

Apheresis, a medical procedure with therapeutic applications, involves the separation and removal of specific blood components from a donor or patient. The process utilizes a sophisticated machine known as an apheresis machine, which allows for the selective extraction and retention of blood components, such as plasma, platelets, red blood cells, or white blood cells. This separation is achieved through centrifugation or filtration, depending on the targeted blood component. One of the primary therapeutic applications of it is in the treatment of various medical conditions, including autoimmune disorders, hematologic diseases, and neurological disorders. For example, in autoimmune diseases like multiple sclerosis or myasthenia gravis, apheresis can remove harmful antibodies from the patient's blood, mitigating the impact of the disease. Similarly, in hematologic disorders like leukemia, apheresis aids in collecting specific blood components for therapeutic use or transplantation. Additionally, it plays a crucial role in blood donation processes, allowing for the collection of specific components needed for various medical treatments while returning the remaining components to the donor. This targeted blood component collection enhances the efficiency of blood donation practices, ensuring a steady and diverse supply of blood products for medical interventions. The evolving field of apheresis continues to contribute to advancements in therapeutic and donation-related medical practices, providing clinicians with a powerful tool to selectively manage blood components to benefit patients facing a spectrum of health challenges.

JAPAN APHERESIS MARKET TRENDS:

The market in Japan is majorly driven by the expanding scope of therapeutic applications. In line with this, the rapid advancements in apheresis machine technologies contribute significantly to market growth. Continuous innovations in device design, automation, and precision in blood component separation enhance the efficiency and safety of apheresis procedures, making them more accessible and attractive to healthcare providers. These technological enhancements also lead to reduced procedure times and improved patient comfort, further driving the adoption of apheresis in clinical settings. Furthermore, the rising prevalence of chronic and autoimmune diseases fuels the demand for apheresis procedures. Conditions such as cancer, autoimmune disorders, and hematologic diseases often require targeted removal or collection of specific blood components to manage symptoms or facilitate treatments. Apheresis serves as a crucial therapeutic intervention by allowing the selective extraction of disease-related components, contributing to disease management and improving patient outcomes. As the burden of chronic diseases continues to increase, the demand for apheresis procedures as a therapeutic option is expected to grow. Besides, the widespread therapeutic applications for apheresis broaden its market potential. Beyond traditional uses, apheresis is finding applications in neurology, nephrology, and hematology, among other medical specialties. This diversification of applications positions apheresis as a versatile and valuable tool in various healthcare scenarios, contributing to its sustained market growth. Additionally, the growing awareness among healthcare professionals about the benefits of apheresis in managing a wide range of medical conditions further propels its adoption.

JAPAN APHERESIS MARKET SEGMENTATION:

Component Insights:

  • To get detailed segment analysis of this market Request Sample
  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or Leukopheresis)
  • Lymphocytes (Lymphopheresis or Lymphapheresis)
  • RBC's (Erythropheresis)
  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or Leukopheresis)
  • Lymphocytes (Lymphopheresis or Lymphapheresis)
  • RBC's (Erythropheresis)

Product Insights:

  • Devices
  • Disposables and Reagents
  • Software
  • Devices
  • Disposables and Reagents
  • Software

Technology Insights:

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption
  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Procedure Insights:

  • Donor/Automated Apheresis
  • Therapeutic Apheresis
  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Application Insights:

  • Renal Disorders
  • Hematological Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Others
  • Renal Disorders
  • Hematological Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Others

End User Insights:

  • Blood Centers
  • Hospitals
  • Others
  • Blood Centers
  • Hospitals
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan apheresis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan apheresis market?
  • What is the breakup of the Japan apheresis market on the basis of component?
  • What is the breakup of the Japan apheresis market on the basis of product?
  • What is the breakup of the Japan apheresis market on the basis of technology?
  • What is the breakup of the Japan apheresis market on the basis of procedure?
  • What is the breakup of the Japan apheresis market on the basis of application?
  • What is the breakup of the Japan apheresis market on the basis of end user?
  • What are the various stages in the value chain of the Japan apheresis market?
  • What are the key driving factors and challenges in the Japan apheresis?
  • What is the structure of the Japan apheresis market and who are the key players?
  • What is the degree of competition in the Japan apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Apheresis Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Apheresis Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Apheresis Market - Breakup by Component

  • 6.1 Plasma (Plasmapheresis)
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Platelets (Plateletpheresis)
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Leukocytes (Leukapheresis or Leukopheresis)
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 RBC's (Erythropheresis)
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)

7 Japan Apheresis Market - Breakup by Product

  • 7.1 Devices
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Disposables and Reagents
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Software
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)

8 Japan Apheresis Market - Breakup by Technology

  • 8.1 Centrifugation
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Membrane Separation
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Selective Adsorption
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Apheresis Market - Breakup by Procedure

  • 9.1 Donor/Automated Apheresis
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Therapeutic Apheresis
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Apheresis Market - Breakup by Application

  • 10.1 Renal Disorders
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Hematological Disorders
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Neurological Disorders
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Autoimmune Disorders
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Forecast (2026-2034)
  • 10.5 Others
    • 10.5.1 Historical and Current Market Trends (2020-2025)
    • 10.5.2 Market Forecast (2026-2034)

11 Japan Apheresis Market - Breakup by End User

  • 11.1 Blood Centers
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Forecast (2026-2034)
  • 11.2 Hospitals
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Forecast (2026-2034)
  • 11.3 Others
    • 11.3.1 Historical and Current Market Trends (2020-2025)
    • 11.3.2 Market Forecast (2026-2034)

12 Japan Apheresis Market - Breakup by Region

  • 12.1 Kanto Region
    • 12.1.1 Overview
    • 12.1.2 Historical and Current Market Trends (2020-2025)
    • 12.1.3 Market Breakup by Component
    • 12.1.4 Market Breakup by Product
    • 12.1.5 Market Breakup by Technology
    • 12.1.6 Market Breakup by Procedure
    • 12.1.7 Market Breakup by Application
    • 12.1.8 Market Breakup by End User
    • 12.1.9 Key Players
    • 12.1.10 Market Forecast (2026-2034)
  • 12.2 Kansai/Kinki Region
    • 12.2.1 Overview
    • 12.2.2 Historical and Current Market Trends (2020-2025)
    • 12.2.3 Market Breakup by Component
    • 12.2.4 Market Breakup by Product
    • 12.2.5 Market Breakup by Technology
    • 12.2.6 Market Breakup by Procedure
    • 12.2.7 Market Breakup by Application
    • 12.2.8 Market Breakup by End User
    • 12.2.9 Key Players
    • 12.2.10 Market Forecast (2026-2034)
  • 12.3 Central/ Chubu Region
    • 12.3.1 Overview
    • 12.3.2 Historical and Current Market Trends (2020-2025)
    • 12.3.3 Market Breakup by Component
    • 12.3.4 Market Breakup by Product
    • 12.3.5 Market Breakup by Technology
    • 12.3.6 Market Breakup by Procedure
    • 12.3.7 Market Breakup by Application
    • 12.3.8 Market Breakup by End User
    • 12.3.9 Key Players
    • 12.3.10 Market Forecast (2026-2034)
  • 12.4 Kyushu-Okinawa Region
    • 12.4.1 Overview
    • 12.4.2 Historical and Current Market Trends (2020-2025)
    • 12.4.3 Market Breakup by Component
    • 12.4.4 Market Breakup by Product
    • 12.4.5 Market Breakup by Technology
    • 12.4.6 Market Breakup by Procedure
    • 12.4.7 Market Breakup by Application
    • 12.4.8 Market Breakup by End User
    • 12.4.9 Key Players
    • 12.4.10 Market Forecast (2026-2034)
  • 12.5 Tohoku Region
    • 12.5.1 Overview
    • 12.5.2 Historical and Current Market Trends (2020-2025)
    • 12.5.3 Market Breakup by Component
    • 12.5.4 Market Breakup by Product
    • 12.5.5 Market Breakup by Technology
    • 12.5.6 Market Breakup by Procedure
    • 12.5.7 Market Breakup by Application
    • 12.5.8 Market Breakup by End User
    • 12.5.9 Key Players
    • 12.5.10 Market Forecast (2026-2034)
  • 12.6 Chugoku Region
    • 12.6.1 Overview
    • 12.6.2 Historical and Current Market Trends (2020-2025)
    • 12.6.3 Market Breakup by Component
    • 12.6.4 Market Breakup by Product
    • 12.6.5 Market Breakup by Technology
    • 12.6.6 Market Breakup by Procedure
    • 12.6.7 Market Breakup by Application
    • 12.6.8 Market Breakup by End User
    • 12.6.9 Key Players
    • 12.6.10 Market Forecast (2026-2034)
  • 12.7 Hokkaido Region
    • 12.7.1 Overview
    • 12.7.2 Historical and Current Market Trends (2020-2025)
    • 12.7.3 Market Breakup by Component
    • 12.7.4 Market Breakup by Product
    • 12.7.5 Market Breakup by Technology
    • 12.7.6 Market Breakup by Procedure
    • 12.7.7 Market Breakup by Application
    • 12.7.8 Market Breakup by End User
    • 12.7.9 Key Players
    • 12.7.10 Market Forecast (2026-2034)
  • 12.8 Shikoku Region
    • 12.8.1 Overview
    • 12.8.2 Historical and Current Market Trends (2020-2025)
    • 12.8.3 Market Breakup by Component
    • 12.8.4 Market Breakup by Product
    • 12.8.5 Market Breakup by Technology
    • 12.8.6 Market Breakup by Procedure
    • 12.8.7 Market Breakup by Application
    • 12.8.8 Market Breakup by End User
    • 12.8.9 Key Players
    • 12.8.10 Market Forecast (2026-2034)

13 Japan Apheresis Market - Competitive Landscape

  • 13.1 Overview
  • 13.2 Market Structure
  • 13.3 Market Player Positioning
  • 13.4 Top Winning Strategies
  • 13.5 Competitive Dashboard
  • 13.6 Company Evaluation Quadrant

14 Profiles of Key Players

  • 14.1 Company A
    • 14.1.1 Business Overview
    • 14.1.2 Product Portfolio
    • 14.1.3 Business Strategies
    • 14.1.4 SWOT Analysis
    • 14.1.5 Major News and Events
  • 14.2 Company B
    • 14.2.1 Business Overview
    • 14.2.2 Product Portfolio
    • 14.2.3 Business Strategies
    • 14.2.4 SWOT Analysis
    • 14.2.5 Major News and Events
  • 14.3 Company C
    • 14.3.1 Business Overview
    • 14.3.2 Product Portfolio
    • 14.3.3 Business Strategies
    • 14.3.4 SWOT Analysis
    • 14.3.5 Major News and Events
  • 14.4 Company D
    • 14.4.1 Business Overview
    • 14.4.2 Product Portfolio
    • 14.4.3 Business Strategies
    • 14.4.4 SWOT Analysis
    • 14.4.5 Major News and Events
  • 14.5 Company E
    • 14.5.1 Business Overview
    • 14.5.2 Product Portfolio
    • 14.5.3 Business Strategies
    • 14.5.4 SWOT Analysis
    • 14.5.5 Major News and Events

15 Japan Apheresis Market - Industry Analysis

  • 15.1 Drivers, Restraints, and Opportunities
    • 15.1.1 Overview
    • 15.1.2 Drivers
    • 15.1.3 Restraints
    • 15.1.4 Opportunities
  • 15.2 Porters Five Forces Analysis
    • 15.2.1 Overview
    • 15.2.2 Bargaining Power of Buyers
    • 15.2.3 Bargaining Power of Suppliers
    • 15.2.4 Degree of Competition
    • 15.2.5 Threat of New Entrants
    • 15.2.6 Threat of Substitutes
  • 15.3 Value Chain Analysis

16 Appendix